Yang et al. (87) demonstrated that cryptotanshinone lowers testosterone levels in HCG and Ins-induced PCOS rat models by inhibiting the HMGB1/TLR4/NF-κB signaling pathway, ultimately improving reproductive function. Here, HMGB1 is linked to polycystic ovary syndrome.